Market revenue in 2024 | USD 6,787.1 million |
Market revenue in 2030 | USD 11,437.2 million |
Growth rate | 9.1% (CAGR from 2025 to 2030) |
Largest segment | Psoriasis |
Fastest growing segment | Psoriasis |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.27% in 2024. Horizon Databook has segmented the Europe dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatological drugs market in Europe is experiencing growth, driven by the increasing prevalence of skin conditions such as eczema, psoriasis, and acne. Well-established healthcare systems and the growing demand for therapeutic and aesthetic dermatological treatments support the market. The development of advanced drug formulations and innovations in treatment options further contribute to market growth across key European countries.
Key drivers in the European dermatological drugs market include the rise in skin disorders and the aging population, which increases the demand for anti-aging and dermatological treatments. Furthermore, the growing awareness of dermatological conditions, combined with advancements in biologics and other specialized therapies, supports the adoption of new treatments. The increasing availability of telemedicine services enhances access to dermatological care, expanding the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dermatological drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account